AMSS values (baseline, 30-week, and change) stratified (< 8 and ≥ 8) by HADS-D and HADS-A values
| Patient groups | Baseline AMSS: median (IQR) | 30-week AMSS: median (IQR) | ∆AMSS: median (IQR) |
|---|---|---|---|
| HADS-D ≥ 8 | |||
| P, n = 44 | 45 (39, 54) | 44.5 (36.5, 50) | –3 (–9, 3) |
| TU, n = 35 | 50 (42, 55) | 42 (31, 51) | –6 (–11, 1) |
| HADS-D < 8 | |||
| P, n = 50 | 34 (27, 38) | 31 (26, 41) | –2 (–5, 3) |
| TU, n = 41 | 35 (31, 40) | 31(28, 35) | –5 (–7, –1) |
| HADS-A ≥ 8 | |||
| P, n = 34 | 45 (38, 57) | 44 (31, 53) | –2.5 (–10, 2) |
| TU, n = 37 | 47 (40, 54) | 41 (31, 51) | –3 (–10, 2) |
| HADS-A < 8 | |||
| P, n = 60 | 36 (29.5, 41) | 34.5 (26.5, 42) | –2 (–6, 3) |
| TU, n = 39 | 35 (32, 41) | 31 (27, 38) | –6 (–9, –2) |
∆AMSS: changes in ageing male symptom scale; HADS-A: Hospital Anxiety and Depression Scale-anxiety; HADS-D: Hospital Anxiety and Depression Scale-depression; IQR: interquartile range; P: placebo; TU: testosterone undecanoate